News Release

View printer-friendly version << Back

AcelRx Pharmaceuticals Scheduled to Present at the JP Morgan Healthcare Conference in San Francisco on January 15, 2009

REDWOOD CITY, Calif., December 23, 2008 -- AcelRx Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the treatment of intermittent and acute conditions, with an initial emphasis on pain management, announced that it will present at JP Morgan’s 27th Annual Healthcare Conference, to be held on Thursday, January 15th, 2009 at the Westin St. Francis Hotel in San Francisco. The AcelRx Pharmaceuticals, Inc., presentation is scheduled to begin at 11:00a.m. Pacific Standard Time. AcelRx Pharmaceuticals, Inc., will make a presentation on the Company, including recent positive Phase 2 clinical trial results.

AcelRx Pharmaceuticals, Inc.
Carter King
Vice President, Finance